Sanofi (NASDAQ:SNY) Shares Bought by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. increased its stake in Sanofi (NASDAQ:SNY) by 9.0% in the 1st quarter, Holdings Channel.com reports. The fund owned 7,063 shares of the company’s stock after acquiring an additional 582 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Sanofi were worth $343,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Boston Partners increased its position in shares of Sanofi by 1.9% during the fourth quarter. Boston Partners now owns 13,032,746 shares of the company’s stock worth $648,617,000 after purchasing an additional 245,682 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Sanofi by 16.5% in the first quarter. Bank of New York Mellon Corp now owns 7,224,508 shares of the company’s stock valued at $351,111,000 after acquiring an additional 1,021,077 shares in the last quarter. Raymond James & Associates grew its position in shares of Sanofi by 26.9% during the first quarter. Raymond James & Associates now owns 2,315,255 shares of the company’s stock worth $112,521,000 after buying an additional 491,498 shares in the last quarter. Brandes Investment Partners LP raised its holdings in shares of Sanofi by 64.6% in the 4th quarter. Brandes Investment Partners LP now owns 1,770,572 shares of the company’s stock valued at $88,051,000 after purchasing an additional 694,957 shares in the last quarter. Finally, DAVENPORT & Co LLC lifted its holdings in Sanofi by 32.4% during the 1st quarter. DAVENPORT & Co LLC now owns 1,549,229 shares of the company’s stock worth $75,674,000 after buying an additional 378,860 shares during the last quarter. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Stock Down 0.1 %

Shares of NASDAQ SNY opened at $51.14 on Friday. The stock has a market cap of $129.52 billion, a PE ratio of 25.73, a price-to-earnings-growth ratio of 1.58 and a beta of 0.59. The business has a 50-day moving average price of $48.84 and a 200 day moving average price of $48.64. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. Sanofi has a 52-week low of $42.63 and a 52-week high of $55.72.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.96. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. The firm had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. Equities research analysts forecast that Sanofi will post 4.14 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.